February 27, 2020 / 9:28 PM / in a month

BRIEF-Oyster Point Pharma Reports Q4 Loss Per Share $1.41

Feb 27 (Reuters) - Oyster Point Pharma Inc:

* OYSTER POINT PHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS

* Q4 LOSS PER SHARE $1.41

* AS OF DECEMBER 31, 2019, CASH AND CASH EQUIVALENTS WERE $139.1 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below